A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : CTX

Search Conditions:
Search Keyword : CTX
Search Method : Exact match.
Research Area:

Results:  
Hit abbr.: 2 kinds.
(Click one to see its hit entries.)

(Appearance freq, Descending)
Abbreviation: CTX
Appearance Frequency: 1912 time(s)
Long forms: 111

Display Settings:
[Display Entries]
Long Form, 100 entries
    (Appearance freq, Descending)
Long Form, all entries
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
cefotaxime
(351 times)
Anti-Bacterial Agents
(121 times)
CAZ (66 times)
dCTX (29 times)
CPZ (24 times)
1980 [Experimental and clinical studies on cefoperazone (author's transl)].
cerebrotendinous xanthomatosis
(288 times)
Neurology
(76 times)
CDCA (29 times)
LDL (9 times)
MRI (9 times)
1973 The metabolism of cholestanol, cholesterol, and bile acids in cerebrotendinous xanthomatosis.
cholera toxin
(281 times)
Biochemistry
(48 times)
PTX (92 times)
PKC (23 times)
cAMP (18 times)
1980 Cholera toxin stimulates adenosine 3',5'-monophosphate synthesis and epithelial wound closure in the rabbit cornea.
charybdotoxin
(153 times)
Physiology
(64 times)
TEA (35 times)
4-AP (18 times)
ACh (15 times)
1987 Blocking agents of Ca2+-activated K+ channels in cultured medullary thick ascending limb cells.
cortex
(106 times)
Neurology
(42 times)
STR (10 times)
HIP (7 times)
POA (6 times)
1980 The effect of amygdaloid and hippocampal lesions on compensatory ovulation and pro-oestrous gonadotropin levels in the rat.
cardiotoxin
(95 times)
Physiology
(20 times)
TA (10 times)
WT (7 times)
PLA2 (4 times)
1972 Role of cardiotoxin and phospholipase A in the blockade of nerve conduction and depolarization of skeletal muscle induced by cobra venom.
carboxy-terminal telopeptide of type I collagen
(49 times)
Metabolism
(14 times)
BMD (11 times)
BALP (9 times)
OC (7 times)
1997 New biochemical markers of bone resorption in the study of postmenopausal osteoporosis.
ciguatoxin
(48 times)
Toxicology
(12 times)
CFP (7 times)
MAb-CTX (4 times)
ELISA (3 times)
1981 Mode of the excitatory and inhibitory actions of ciguatoxin in the guinea-pig vas deferens.
cetuximab
(47 times)
Neoplasms
(23 times)
EGFR (12 times)
OS (7 times)
NTZ (6 times)
2008 KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab.
10  chlorotoxin
(47 times)
Biomedical Engineering
(10 times)
GBM (8 times)
PEG (7 times)
MRI (6 times)
1998 Use of chlorotoxin for targeting of primary brain tumors.
11  cotrimoxazole
(45 times)
Acquired Immunodeficiency Syndrome
(14 times)
ART (12 times)
CI (5 times)
HIV (4 times)
1983 Comparative effects of cotrimoxazole (trimethoprim-sulphamethoxazole), pyrimethamine-sulphadiazine and spiramycin during avirulent infection with Toxoplasma gondii (Beverley strain) in mice.
12  ceftriaxone
(38 times)
Drug Therapy
(6 times)
GLT-1 (4 times)
CIP (3 times)
DHK (3 times)
1993 [Clinical pharmacokinetics of ceftriaxone during the third trimester of pregnancy and study of its transplacental passage in two patients].
13  carboxy-terminal collagen crosslinks
(33 times)
Endocrinology
(8 times)
BMD (8 times)
OPG (5 times)
PTH (5 times)
2000 Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy.
14  cytoxan
(31 times)
Complementary Therapies
(11 times)
ADR (3 times)
ATG (3 times)
ELISA (3 times)
1978 Combination modality therapy in lung cancer: a survival study showing beneficial results of AMCOF (adriamycin, methotrexate, cyclophosphamide, oncovin and 5-fluorouracil).
15  Crotoxin
(25 times)
Toxicology
(11 times)
CdtV (2 times)
CsA (2 times)
FPRs (2 times)
1998 Secreted phospholipase A2-induced neurotoxicity and epileptic seizures after intracerebral administration: an unexplained heterogeneity as emphasized with paradoxin and crotoxin.
16  chemotaxis
(22 times)
Hematology
(5 times)
fMLP (5 times)
PMN (3 times)
Aa (2 times)
1977 Delayed hypersensitivity: indicator of acquired failure of host defenses in sepsis and trauma.
17  omega-conotoxin
(22 times)
Pharmacology
(9 times)
TTX (5 times)
EFS (3 times)
Aga (2 times)
1988 The effect of omega conotoxin GVIA, a peptide modulator of the N-type voltage sensitive calcium channels, on motor responses produced by activation of efferent and sensory nerves in mammalian smooth muscle.
18  carboxy-terminal telopeptide
(19 times)
Medicine
(5 times)
BMD (5 times)
OC (5 times)
bAP (3 times)
1997 Metabolic improvement of poorly controlled noninsulin-dependent diabetes mellitus decreases bone turnover.
19  canthaxanthin
(17 times)
Biochemistry
(5 times)
BC (4 times)
LUT (2 times)
LYC (2 times)
1988 Beta-carotene and canthaxanthin inhibit chemically- and physically-induced neoplastic transformation in 10T1/2 cells.
20  cardiotoxicity
(17 times)
Cardiology
(14 times)
ANTs (2 times)
CMR (2 times)
ANT (1 time)
1986 Clinical and non-invasive assessment of anthracycline cardiotoxicity: perspectives on myocardial protection.
21  omega-conotoxin GVIA
(15 times)
Pharmacology
(6 times)
125I-CTX (1 time)
ACC (1 time)
AgTx (1 time)
1988 Evidence for two independent modes of activation of the 'efferent' function of capsaicin-sensitive nerves.
22  cytotoxicity
(14 times)
Allergy and Immunology
(7 times)
NK (4 times)
ALGVH (2 times)
CGVH (2 times)
1975 Cytotoxic reactions of murine lymphoid cells studied with a tritiated proline microcytotoxicity test.
23  cytotoxin
(13 times)
Molecular Biology
(4 times)
cos (2 times)
NTX (2 times)
PBMC (2 times)
1985 Involvement of cytotoxins in the immune response to viral infection.
24  cabazitaxel
(12 times)
Pharmacology
(3 times)
AFM (1 time)
CLSM (1 time)
CTX-PLMs (1 time)
2015 Decreased Core Crystallinity Facilitated Drug Loading in Polymeric Micelles without Affecting Their Biological Performances.
25  Cotrimoxazole
(10 times)
Medicine
(5 times)
ART (4 times)
HEU (2 times)
HUU (2 times)
2013 Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review.
26  cobratoxin
(7 times)
Pharmacology
(4 times)
AA (2 times)
ACh (1 time)
AChRs (1 time)
2001 Nicotinic receptors in Lymnaea stagnalis neurons are blocked by alpha-neurotoxins from cobra venoms.
27  alpha-cobratoxin
(5 times)
Biochemistry
(2 times)
AChR (1 time)
Alexa-alphaBgt (1 time)
Bt-CTX (1 time)
1990 Crystallization and preliminary x-ray diffraction study of neurotoxin-I from Naja naja oxiana venom.
28  cytotoxic
(4 times)
Neoplasms
(2 times)
BCG (1 time)
CDAC (1 time)
CF (1 time)
1983 Humoral response of melanoma patients to two different tumor-associated antigens.
29  cefotaxime sodium
(3 times)
Microbiology
(1 time)
ASA (1 time)
BCTX (1 time)
CAZ (1 time)
1990 [Antigenicity study of cefpirome sulfate].
30  conotoxins
(3 times)
Biochemistry
(2 times)
--- 2006 Novel alpha-conotoxins identified by gene sequencing from cone snails native to Hainan, and their sequence diversity.
31  cortical thymocyte marker in Xenopus
(3 times)
Hematology
(1 time)
ACAM (1 time)
IgSF (1 time)
JAM (1 time)
2004 Immunoglobulin superfamily receptors in protochordates: before RAG time.
32  2-chloro-9H-thioxanthen-9-one
(2 times)
Nutritional Sciences
(2 times)
BP (2 times)
CPTX (2 times)
EA (2 times)
2014 Evaluation of the migration of 15 photo-initiators from cardboard packaging into Tenax() using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS).
33  2-chlorothioxanthone
(2 times)
Biochemistry
(2 times)
CPTX (1 time)
2009 Photophysics and photochemistry of z-chlorprothixene in acetonitrile.
34  cardiovascular toxicity
(2 times)
Metabolism
(1 time)
ROS (1 time)
2017 From Molecular Mechanisms to Clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: A Translational Overview.
35  ceftriaxone sodium
(2 times)
Colloids
(1 time)
ALG (1 time)
bFGF (1 time)
CLSM (1 time)
2012 Enhanced antibacterial effect of ceftriaxone sodium-loaded chitosan nanoparticles against intracellular Salmonella typhimurium.
36  cetrorelix acetate
(2 times)
Endocrinology
(1 time)
ACT (1 time)
CT (1 time)
DBCP (1 time)
2013 Assessment of inhibin B as a biomarker of testicular injury following administration of carbendazim, cetrorelix, or 1,2-dibromo-3-chloropropane in Wistar han rats.
37  cholera-toxin encoding phage
(2 times)
Microbiology
(1 time)
cla (1 time)
IL-6 (1 time)
MIP-2 (1 time)
2014 Vibrio cholerae-induced inflammation in the neonatal mouse cholera model.
38  chylothorax
(2 times)
Cardiology
(2 times)
CHD (1 time)
CVC (1 time)
CVT (1 time)
2008 Postoperative chylothorax development is associated with increased incidence and risk profile for central venous thromboses.
39  cotrimoxazole prophylaxis
(2 times)
Acquired Immunodeficiency Syndrome
(1 time)
HAART (2 times)
DALYs (1 time)
RPC (1 time)
2006 The costs and benefits of private sector provision of treatment to HIV-infected employees in Kampala, Uganda.
40  cytotoxic chemotherapy
(2 times)
Neoplasms
(1 time)
BSC (1 time)
CENTRAL (1 time)
CI (1 time)
2001 Effect of human urinary macrophage colony-stimulating factor on the immune functions and the blood cell counts in patients with ovarian carcinoma receiving cytotoxic chemotherapy.
41  AC--cholera toxin
(1 time)
Pharmacology
(1 time)
AC (1 time)
db cyclic AMP (1 time)
Gs (1 time)
1988 Role of stimulatory GTP-binding protein (Gs) in reduced beta-adrenoceptor coupling in the femoral artery of spontaneously hypertensive rats.
42  C-Telopeptides X
(1 time)
Communicable Diseases
(1 time)
HAART (1 time)
PTH (1 time)
SHD (1 time)
2013 Severe hypovitaminosis D correlates with increased inflammatory markers in HIV infected patients.
43  carboxy-terminal cross-links
(1 time)
Pathology
(1 time)
--- 2010 The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone increases bone resorption in women with type 2 diabetes: a randomized, controlled trial.
44  carboxy-terminal-cross-linked-telopeptide of type-I-collagen
(1 time)
Geriatrics
(1 time)
BRM (1 time)
CY (1 time)
FY (1 time)
2015 Fortification of Yogurts with Vitamin D and Calcium Enhances the Inhibition of Serum Parathyroid Hormone and Bone Resorption Markers: A Double Blind Randomized Controlled Trial in Women over 60 Living in a Community Dwelling Home.
45  carboxyterminal cross linking teleopeptide
(1 time)
Biology
(1 time)
FTIR (1 time)
PINP (1 time)
TCDD (1 time)
2009 Short-term exposure to dioxin impairs bone tissue in male rats.
46  cardiotoxic effects of cyclophosphamide
(1 time)
Biochemistry
(1 time)
4HPC (1 time)
BSO (1 time)
1994 Effect of sulfhydryl compounds and glutathione depletion on rat heart myocyte toxicity induced by 4-hydroperoxycyclophosphamide and acrolein in vitro.
47  Cefotax
(1 time)
Urology
(1 time)
--- 1987 [Clinical evaluation of combination therapy with Fortimicin and Cefotax in the treatment of complicated urinary tract infections].
48  cefotaxime alone
(1 time)
Neurosurgery
(1 time)
CTX-FOS (1 time)
CTX-VAN (1 time)
SSI (1 time)
2002 Empirical treatment of adult postsurgical nosocomial meningitis.
49  cefotaxime prophylaxis
(1 time)
Cardiology
(1 time)
BPC (1 time)
1988 Comparison between cefotaxime and a combination of benzylpenicillin and cloxacillin as an antibiotic prophylaxis in cardiac surgery with cardio-pulmonary bypass.
50  cefotaxime-beta lactamases
(1 time)
Drug Therapy
(1 time)
ESBL (1 time)
MDR (1 time)
MIC (1 time)
2015 Epidemiology of CTX-M-type extended-spectrum beta-lactamase (ESBL)-producing nosocomial -Escherichia coli infection in China.
51  central Texas
(1 time)
Microbiological Phenomena
(1 time)
NTX (1 time)
NY (1 time)
PA (1 time)
2017 Temporal Genomic Phylogeny Reconstruction Indicates a Geospatial Transmission Path of Salmonella Cerro in the United States and a Clade-Specific Loss of Hydrogen Sulfide Production.
52  cerebral toxoplasmosis
(1 time)
Communicable Diseases
(1 time)
aIRR (1 time)
CI (1 time)
2017 Incidence, presentation and outcome oftoxoplasmosis in HIV infected in the combination antiretroviral therapy era.
53  cetuximab in combination with platinum-based chemotherapy
(1 time)
Drug Therapy
(1 time)
AC (1 time)
ERG (1 time)
NICE (1 time)
2010 Cetuximab for recurrent and/or metastatic squamous cell carcinoma of the head and neck: a NICE single technology appraisal.
54  cetuximab plus chemotherapy
(1 time)
Health Services Research
(1 time)
ERG (1 time)
ICER (1 time)
NICE (1 time)
2009 Cetuximab for the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck.
55  charybdotoxin sensitive
(1 time)
Molecular Biology
(1 time)
MIA (1 time)
RVD (1 time)
1999 Increases in intracellular pH and Ca(2+) are essential for K(+) channel activation after modest 'physiological' swelling in villus epithelial cells.
56  chemoimmune prophylaxis with i.v. cyclophosphamide
(1 time)
Urology
(1 time)
FCM (1 time)
1984 Cytomorphological and histological studies on the urothelium during and after chemoimmune prophylaxis.
57  chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide
(1 time)
Neoplasms
(1 time)
CI (1 time)
1996 Treatment-related leukemia in breast cancer patients treated with fluorouracil-doxorubicin-cyclophosphamide combination adjuvant chemotherapy: the University of Texas M.D. Anderson Cancer Center experience.
58  cholera toxin and theophylline
(1 time)
Pharmacology
(1 time)
cAMP (1 time)
Con A (1 time)
1984 Effects of concanavalin A and cholera toxin on epidermal cAMP and migration rate during wound closure in adult newts.
59  cholera toxin B subunit
(1 time)
Neurology
(1 time)
alpha7nAChR (1 time)
2001 Membrane lipid rafts are necessary for the maintenance of the (alpha)7 nicotinic acetylcholine receptor in somatic spines of ciliary neurons.
60  cholera toxin encoding element
(1 time)
Biology
(1 time)
--- 2008 Comparison of distribution of virulence determinants in clinical and environmental isolates of Vibrio cholera.
61  cholera toxin prophage
(1 time)
Medicine
(1 time)
SNPs (1 time)
2014 Second-pandemic strain of Vibrio cholerae from the Philadelphia cholera outbreak of 1849.
62  cholera toxin subunit B
(1 time)
Biosensing Techniques
(1 time)
ELISA (1 time)
PCEPy (1 time)
POC (1 time)
2019 On-Chip Electrochemical Detection of Cholera Using a Polypyrrole-Functionalized Dendritic Gold Sensor.
63  Cholera ToXins
(1 time)
Microbiology
(1 time)
--- 2012 In silico analyses of primers used to detect the pathogenicity genes of Vibrio cholerae.
64  Chrysotoxine
(1 time)
Biomedical Engineering
(1 time)
--- 2014 Determination of chrysotoxine in rat plasma by liquid chromatography-tandem mass spectrometry and its application to a rat pharmacokinetic study.
65  cis-thiothixene
(1 time)
Drug Therapy
(1 time)
--- 1991 A simple, sensitive liquid chromatographic assay of cis-thiothixene in plasma with coulometric detection.
66  clavulanate resistance was unexpectedly reduced from 8-24
(1 time)
Pathology
(1 time)
--- 2009 Paradoxical effect of Klebsiella pneumoniae OmpK36 porin deficiency.
67  clinical isolates of BLNAR, MEPM+cefotaxime
(1 time)
Anti-Bacterial Agents
(1 time)
BLNAR (1 time)
MEPM (1 time)
PRSP (1 time)
2005 [In vitro combined effect of meropenem and various antimicrobial agents against beta-lactamase-nonproducing ampicillin-resistant Haemophilus influenzae and penicillin-resistant Streptococcus pneumoniae].
68  Clinical Trial Exemption
(1 time)
Laboratory Techniques and Procedures
(1 time)
IND (1 time)
MAA (1 time)
NDA (1 time)
2001 The selection of marmoset monkeys (Callithrix jacchus) in pharmaceutical toxicology.
69  clinical trial, treatment with cefotaxime
(1 time)
Pediatrics
(1 time)
CSF (1 time)
ST (1 time)
1988 Cefotaxime versus penicillin-chloramphenicol in purulent meningitis: a controlled single-blind clinical trial.
70  closed-skull TBI with a cardiotoxin
(1 time)
Neurology
(1 time)
TBI (2 times)
MULTI (1 time)
SHAM (1 time)
2018 A Concomitant Muscle Injury Does Not Worsen Traumatic Brain Injury Outcomes in Mice.
71  coli to ceftriaxone
(1 time)
Medicine
(1 time)
APN (1 time)
E. coli (1 time)
2012 In vivo susceptibility of ESBL producing Escherichia coli to ceftriaxone in children with acute pyelonephritis.
72  commonly found toxin and a potent metabolite of cyclophosphamide
(1 time)
Biochemistry
(1 time)
ROS (1 time)
2018 Acrolein, a commonly found environmental toxin, causes oocyte mitochondrial dysfunction and negatively affects embryo development.
73  compare the effectiveness of cytoxan
(1 time)
Neoplasms
(1 time)
BL (1 time)
CNS (1 time)
1976 Treatment of Burkitt's lymphoma: randomized clinical trial of single-agent versus combination chemotherapy.
74  compared to ceftriaxone
(1 time)
Biochemistry
(1 time)
--- 2012 Design and synthesis of 2-aminothiazole based antimicrobials targeting MRSA.
75  compared to those of cefotaxime
(1 time)
Anti-Bacterial Agents
(1 time)
CMNX (1 time)
LMOX (1 time)
1988 [Antibacterial activity of cefminox in human urine].
76  concentration, the pharmacokinetics of cefotaxime
(1 time)
Drug Therapy
(1 time)
DACM (1 time)
1984 Pharmacokinetics of cefotaxime and desacetyl-cefotaxime in cirrhosis of the liver.
77  congenital toxoplasmosis
(1 time)
Obstetrics
(1 time)
--- 2011 Prenatal brain imaging in congenital toxoplasmosis.
78  conjugated to chlorotoxin
(1 time)
Nanotechnology
(1 time)
BBB (1 time)
GBM (1 time)
PLGA (1 time)
2016 A Combined Approach Employing Chlorotoxin-Nanovectors and Low Dose Radiation To Reach Infiltrating Tumor Niches in Glioblastoma.
79  conjugation, the resistance to cefotaxime
(1 time)
Virology
(1 time)
AP-271 (1 time)
AZA (1 time)
CTZ (1 time)
1994 Transfer, by conjugation and transduction, of resistance to ceftazidime and cefotaxime from the same clinical isolate of Pseudomonas aeruginosa.
80  containing therapeutic concentrations of cefotaxime
(1 time)
Drug Therapy
(1 time)
ESBLs (1 time)
MIC (1 time)
2002 Selection of Klebsiella pneumoniae mutants with high-level cefotaxime resistance during growth in serum containing therapeutic concentrations of cefotaxime.
81  context
(1 time)
Neurology
(1 time)
G-CTX (1 time)
2017 Effects of context preexposure and delay until anxiety retrieval on generalization of contextual anxiety.
82  Context Cyclophosphamide
(1 time)
Pharmacology
(1 time)
AST (1 time)
i.p (1 time)
IC50 (1 time)
2016 Efficacy of Rosmarinus officinalis leaves extract against cyclophosphamide-induced hepatotoxicity.
83  context exposure
(1 time)
Behavioral Sciences
(1 time)
CeA (1 time)
ERT (1 time)
OBJ (1 time)
2013 Object recognition memory and temporal lobe activation after delayed estrogen replacement therapy.
84  context of systemic chemotherapy cyclophosphamide
(1 time)
Biology
(1 time)
BM (1 time)
DC (1 time)
EAC (1 time)
2017 Synergistic combination of murine bone marrow-derived dendritic cells loaded ex vivo with whole tumor lysate and systemic chemotherapy mediates antitumor immune responses in vivo.
85  context re-exposure alone
(1 time)
Psychophysiology
(1 time)
BLA (1 time)
MUS (1 time)
ST (1 time)
2016 Individual Differences in Animal Stress Models: Considering Resilience, Vulnerability, and the Amygdala in Mediating the Effects of Stress and Conditioned Fear on Sleep.
86  context-CS
(1 time)
Behavioral Sciences
(1 time)
CS (1 time)
fMRI (1 time)
SCR (1 time)
2018 Contingency awareness as a prerequisite for differential contextual fear conditioning.
87  Contractubex
(1 time)
Neurosurgery
(1 time)
BT (1 time)
2018 Comparison of the Effects of Contractubex Gel and Benzothiazole After Topical Application in an Experimental Model of Epidural Fibrosis in Rats.
88  control, the cortex
(1 time)
Sexual Dysfunction, Physiological
(1 time)
AMG (1 time)
AR (1 time)
ARO (1 time)
2015 Steroid Receptors and Aromatase Gene Expression in Different Brain Areas of Copulating and Sexually Sluggish Male Rats.
89  cortical thymocyte Xenopus
(1 time)
Hematology
(1 time)
HEVs (1 time)
2001 Heterogeneity of endothelial junctions is reflected by differential expression and specific subcellular localization of the three JAM family members.
90  cortical thymocyte-specific antigen of Xenopus
(1 time)
Allergy and Immunology
(1 time)
--- 1998 Ontogeny of CTX expression in xenopus.
91  cortical-thymocyte receptors of Xenopus
(1 time)
Biology
(1 time)
DTKR (1 time)
Igs (1 time)
IgSF (1 time)
2004 [Evolutionary development of the immunoglobulins super family].
92  CRT and two existing immunomodulatory drugs: cyclophosphamide
(1 time)
Immunotherapy
(1 time)
CRT (1 time)
HNSCC (1 time)
HPV (1 time)
2019 Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy.
93  ctx gene that encodes cytotoxin
(1 time)
Microbiology
(1 time)
--- 1994 Cytotoxin-converting phages, phi CTX and PS21, are R pyocin-related phages.
94  CTX were positively correlated with i-PTH
(1 time)
Endocrinology
(1 time)
--- 2013 Serum levels of bone resorption markers are decreased in patients with type 2 diabetes.
95  ctx, tcpA, toxR, hlyA, zot, ace, rstR and gIII
(1 time)
Communicable Diseases
(1 time)
PFGE (1 time)
2012 [Molecular analysis on non-O1 and non-O139 Vibrio cholerae isolates].
96  ctx, tcpA, zot, ace, rstR and gIII
(1 time)
Communicable Diseases
(1 time)
PFGE (1 time)
2012 [Molecular analysis on non-O1 and non-O139 Vibrio cholerae isolates].
97  CTX-muscle injury
(1 time)
Neurology
(1 time)
TBI (2 times)
MULTI (1 time)
SHAM (1 time)
2018 A Concomitant Muscle Injury Does Not Worsen Traumatic Brain Injury Outcomes in Mice.
98  CTXphi pIII, we propose to rename OrfU as pIII
(1 time)
Bacteriology
(1 time)
TCP (1 time)
2003 pIIICTX, a predicted CTXphi minor coat protein, can expand the host range of coliphage fd to include Vibrio cholerae.
99  Cyanotoxins
(1 time)
Biochemistry
(1 time)
CB (1 time)
MC (1 time)
2014 Survival, growth and toxicity of Microcystis aeruginosa PCC 7806 in experimental conditions mimicking some features of the human gastro-intestinal environment.
100  cytotoxic agent cyclophosphamide
(1 time)
Cell Biology
(1 time)
OS (1 time)
PFS (1 time)
2017 Ganetespib synergizes with cyclophosphamide to improve survival of mice with autochthonous tumors in a mutant p53-dependent manner.